An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra-abdominal adhesions and wound healing

被引:53
|
作者
Arikan, S
Adas, G
Barut, G
Toklu, AS
Kocakusak, A
Uzun, H
Kemik, W
Daduk, Y
Aydin, S
Purisa, S
机构
[1] Haseki Educ & Res Hosp, Dept Pathol, Istanbul, Turkey
[2] Istanbul Fac Med, Dept Underwater & Hyperbar Med, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpapa Med Fac, Dept Biochem, Istanbul, Turkey
[4] Istanbul Univ, Cerrahpapa Med Fac, Dept Biostat, Istanbul, Turkey
来源
AMERICAN JOURNAL OF SURGERY | 2005年 / 189卷 / 02期
关键词
intra-abdominal adhesion; hyperbaric oxygen; low molecular weight heparin; prevention;
D O I
10.1016/j.amjsurg.2004.11.002
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Abdominal surgery can lead to intra-abdominal adhesions with significant morbidity and mortality. To prevent adhesions, an experimental study was planned to designate the effects of low molecular weight.(LMW) heparins and hyperbaric oxygen (HBO) therapy both on the formation of adhesions and wound healing. Methods: Thirty-eight Wistar albino rats underwent laparotomy to cause intra-abdominal adhesions by mechanical abrasion of the cecum and ethanol application. The rats were divided into 4 groups. In the control group (group 1) no further management was undertaken. Group, 2 was treated by Enoxaparine Na, group 3 received HBO therapy, and group 4 was given both enoxaparine Na and HBO treatment. Results: There was a statistically significant difference between the control and enoxaparine Na groups regarding adhesions. Statistically significant differences were observed between groups 1 and 4 and between groups 1 and 3 regarding the hydroxyproline content of the abdominal wounds. In the pathologic analysis of the abdominal wounds, there was no statistically significant difference between any of the groups, including the control group, regarding inflammation. Statistically significant differences were observed regarding angiogenesis between the control group and groups 3 and 4. There was also a statistically significant difference regarding fibrosis between groups 1 and 4. Conclusions: Enoxaparine Na decreased intra-abdominal adhesions, and HBO therapy had no beneficial effect on adhesions. Enoxaparine Na had no harmful effects on wound healing, and HBO therapy increased the process of wound healing. (C) 2005 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 50 条
  • [42] COST-EFFECTIVENESS OF APIXABAN COMPARED TO LOW MOLECULAR WEIGHT HEPARIN/EDOXABAN FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM
    Lanitis, T.
    Hamilton, M.
    Quon, P.
    Browne, C.
    Masseria, C.
    Cohen, A. T.
    VALUE IN HEALTH, 2015, 18 (07) : A375 - A376
  • [43] Retrospective evaluation to determine the use of unfractionated heparin for the treatment of venous thromboembolism in patients otherwise considered candidates for low molecular weight heparin
    Trepte, Morgan
    Hornsby, Lori
    PHARMACOTHERAPY, 2015, 35 (11): : E193 - E193
  • [44] INVITRO EVALUATION OF A BIOLOGIC GRAFT SURFACE - EFFECT OF TREATMENT WITH CONVENTIONAL AND LOW-MOLECULAR WEIGHT (LMW) HEPARIN
    BJORCK, CG
    BERGQVIST, D
    ESQUIVEL, CO
    LARSSON, R
    RUDSVIK, Y
    THROMBOSIS RESEARCH, 1984, 35 (06) : 653 - 663
  • [45] EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON PREVENTION AND TREATMENT OF DEEP VENOUS THROMBOSIS IN ELDERLY PATIENTS WITH HIP FRACTURE AFTER OPERATION
    Hu, Guodong
    Long, Anhua
    Wang, Jialong
    Zhang, Xuedong
    FARMACIA, 2022, 70 (06) : 1089 - 1096
  • [46] Evaluation of Low-Molecular-Weight Heparin Treatment on First- and Second-Trimester Screening Test Results
    Ak, Mehmet
    Demir, Bertan
    Cundubey, Cevat Rifat
    Cam, Seyma
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [47] COMPARISON OF PENTOSAN POLYSULFATE SODIUM (NA-PPS) WITH A LOW-MOLECULAR-WEIGHT HEPARIN IN THE PREVENTION OF VENOUS THROMBOSIS AFTER ABDOMINAL-SURGERY
    KOLLAR, L
    SCHOLZ, ME
    ROZSOS, I
    PERFUSION, 1994, 7 (04): : 123 - &
  • [48] BENEFIT-RISK-EVALUATION FOR PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARIN PLUS DIHYDROERGOTAMINE
    GETHMANN, U
    BUTTERWEGE, M
    WOLF, H
    WELZEL, D
    PERFUSION, 1990, 3 (05): : 191 - 195
  • [49] Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences
    Lanitis, Tereza
    Leipold, Robert
    Hamilton, Melissa
    Rublee, Dale
    Quon, Peter
    Browne, Chantelle
    Cohen, Alexander T.
    BMC HEALTH SERVICES RESEARCH, 2017, 17 : 1 - 14
  • [50] PREVENTION OF RESTENOSIS AFTER PTCA WITH LONG-TERM TREATMENT OF LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY
    FRIEDRICH, MG
    DECHEND, R
    BARKOWSKI, A
    JUNGNICKEL, K
    BACHER, P
    WELZEL, D
    DIETZ, R
    GULBA, DC
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 981 - 981